1. A Rare Neuromyelitis Optica Mimic: Primary CNS Histiocytic Sarcoma. (5th December 2022) Authors: Rogawski, David; Nirschl, Jeffrey; McDonald, Jamie; Nie, Esther; Schwartz, Nicholas; Vogel, Hannes; Scott, Brian; Gold, Carl; Kipp, Lucas Journal: Neurology Issue: Volume 99:Number 23(2022)Supplement 2 Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Rare Neuromyelitis Optica Mimic: Primary CNS Histiocytic Sarcoma. (5th December 2022) Authors: Rogawski, David; Nirschl, Jeffrey; McDonald, Jamie; Nie, Esther; Schwartz, Nicholas; Vogel, Hannes; Scott, Brian; Gold, Carl; Kipp, Lucas Journal: Neurology Issue: Volume 99:Number 23(2022)Supplement 2 Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Rare Neuromyelitis Optica Mimic: Primary CNS Histiocytic Sarcoma. (5th December 2022) Authors: Rogawski, David; Nirschl, Jeffrey; McDonald, Jamie; Nie, Esther; Schwartz, Nicholas; Vogel, Hannes; Scott, Brian; Gold, Carl; Kipp, Lucas Journal: Neurology Issue: Volume 99:Number 23(2022)Supplement 2 Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Rare Neuromyelitis Optica Mimic: Primary CNS Histiocytic Sarcoma. (5th December 2022) Authors: Rogawski, David; Nirschl, Jeffrey; McDonald, Jamie; Nie, Esther; Schwartz, Nicholas; Vogel, Hannes; Scott, Brian; Gold, Carl; Kipp, Lucas Journal: Neurology Issue: Volume 99:Number 23(2022)Supplement 2 Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Coexistence of Neuromyelitis Optica and Amyotrophic Lateral Sclerosis: A Case Report. (January 2019) Authors: Li, Amy; McGranahan, Tresa; Su, Elaine; Kipp, Lucas; Gold, Carl A. Journal: Neurohospitalist Issue: Volume 9:Number 1(2019) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial. Issue 7 (July 2022) Authors: Foley, John F; Defer, Gilles; Ryerson, Lana Zhovtis; Cohen, Jeffrey A; Arnold, Douglas L; Butzkueven, Helmut; Cutter, Gary; Giovannoni, Gavin; Killestein, Joep; Wiendl, Heinz; Smirnakis, Karen; Xiao, Shan; Kong, George; Kuhelj, Robert; Campbell, Nolan; van der Walt, Anneke; Dwyer, Christopher; Bu... Journal: Lancet neurology Issue: Volume 21:Issue 7(2022) Page Start: 608 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Patient-Reported Benefits of Extracranial Venous Therapy: British Columbia CCSVI Registry. (8th March 2017) Authors: Sadovnick, A. Dessa; Yee, Irene M.; Attwell-Pope, Kristen; Keyes, Glenn; Kipp, Lucas; Traboulsee, Anthony L. Journal: Canadian journal of neurological sciences Issue: Volume 44:Number 3(2017) Page Start: 246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Reduced neurite density in the brain and cervical spinal cord in relapsing–remitting multiple sclerosis: A NODDI study. (November 2020) Authors: Collorone, Sara; Cawley, Niamh; Grussu, Francesco; Prados, Ferran; Tona, Francesca; Calvi, Alberto; Kanber, Baris; Schneider, Torben; Kipp, Lucas; Zhang, Hui; Alexander, Daniel C; Thompson, Alan J; Toosy, Ahmed; Wheeler-Kingshott, Claudia AM Gandini; Ciccarelli, Olga Journal: Multiple sclerosis Issue: Volume 26:Number 13(2020) Page Start: 1647 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗